Related references
Note: Only part of the references are listed.Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
G. Vignir Helgason et al.
BLOOD (2011)
High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
Wolfgang Warsch et al.
BLOOD (2011)
Control of basal autophagy by calpain1 mediated cleavage of ATG5
Hong-guang Xia et al.
AUTOPHAGY (2010)
Inhibition of autophagy induced by overexpression of mda-7/interleukin-24 strongly augments the antileukemia activity in vitro and in vivo
C. Yang et al.
CANCER GENE THERAPY (2010)
Arsenic trioxide induces a beclin-1-independent autophagic pathway via modulation of SnoN/SkiL expression in ovarian carcinoma cells
D. M. Smith et al.
CELL DEATH AND DIFFERENTIATION (2010)
The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-dependent and Beclin 1-independent Cytoprotective Autophagy in Cancer Cells
Ping Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
In Vitro and In Vivo Inhibition of Neuroblastoma Tumor Cell Growth by AKT Inhibitor Perifosine
Zhijie Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines
Dana S. Levy et al.
BLOOD (2009)
Molecular biology of bcr-abl1-positive chronic myeloid leukemia
Alfonso Quintas-Cardama et al.
BLOOD (2009)
Perifosine Inhibits Mammalian Target of Rapamycin Signaling through Facilitating Degradation of Major Components in the mTOR Axis and Induces Autophagy
Lei Fu et al.
CANCER RESEARCH (2009)
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
Cristian Bellodi et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Discovery of Atg5/Atg7-independent alternative macroautophagy
Yuya Nishida et al.
NATURE (2009)
Translation of the Philadelphia chromosome into therapy for CML
Brian J. Druker
BLOOD (2008)
Autophagy in the pathogenesis of disease
Beth Levine et al.
CELL (2008)
The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias
Y. Kamitsuji et al.
CELL DEATH AND DIFFERENTIATION (2008)
Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells
F. Scarlatti et al.
CELL DEATH AND DIFFERENTIATION (2008)
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
Jaclyn LoPiccolo et al.
DRUG RESISTANCE UPDATES (2008)
Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells
Jie Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents
Michael Degtyarev et al.
JOURNAL OF CELL BIOLOGY (2008)
Chronic Myeloid Leukemia Stem Cells
C. H. Jamieson
Hematology-American Society of Hematology Education Program (2008)
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells
V. Papa et al.
LEUKEMIA (2008)
Extended follow-up of a phase 3 trial in relapsed multiple myeloma:: final time-to-event results of the APEX trial
Paul G. Richardson et al.
BLOOD (2007)
Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress
Charleen T. Chu et al.
AUTOPHAGY (2007)
The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway
Heath A. Elrod et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance
Jennifer S. Carew et al.
BLOOD (2007)
The anticancer drug imatinib induces cellular autophagy
A. Ertmer et al.
LEUKEMIA (2007)
Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1
Wenbin Qian et al.
LEUKEMIA RESEARCH (2007)
BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance
Mateusz Koptyra et al.
BLOOD (2006)
Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways
Maria Nyakern et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
Teru Hideshima et al.
BLOOD (2006)
Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development
A Burchert et al.
LEUKEMIA (2005)
Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid
SR Vink et al.
INVESTIGATIONAL NEW DRUGS (2005)
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
M Deininger et al.
BLOOD (2005)
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species
M Rahmani et al.
CANCER RESEARCH (2005)
Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8
L Yu et al.
SCIENCE (2004)
Involvement of Akt kinase in the action of STI571 on chronic myelogenous leukemia cells
K Kawauchi et al.
BLOOD CELLS MOLECULES AND DISEASES (2003)
Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway
GA Ruiter et al.
ANTI-CANCER DRUGS (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Share Paper
